Clinical Trials Logo

Clinical Trial Summary

To assess the influence of seasonal variations in Schistosoma haematobium transmission on treatment outcome (morbidity and re-infection)


Clinical Trial Description

General objective To provide knowledge about the influence of transmission season (high and low) on the outcome of treatment assessed by cure rate, re-infection rate, regression and reappearance of urinary tract morbidity rate after treatment in order to optimise praziquantel treatment strategies for morbidity control in urinary schistosomiasis.

Specific objectives To determine the prevalence and intensity of Schistosoma haematobium infection before chemotherapy and compare cure rates and levels of re-infection after chemotherapy administered during high and low transmission seasons.

To assess urinary tract morbidity due to Schistosoma haematobium by ultrasonography and compare the regression and reappearance of urinary tract pathology chemotherapy administered during high and low transmission seasons.

To correlate morbidity determined by ultrasound with infection and morbidity parameters such as intensity of infection, micro- and macrohematuria, circulating cathodic antigen (CCA) in urine, proteinuria and leucocyturia and determine sensitivity, specificity and positive predictive values in relation to urinary tract morbidity.

Study design The main research question concerning the influence of transmission season on treatment outcome will be addressed in a consecutive cohort study with two separate but comparable cohorts. The first cohort will be examined and treated with praziquantel during the season with high transmission, February/Mach (group A) and the second cohort will be examined and treated during the low transmission season, in July approximately 5 months later (group B). Each cohort will be examined before treatment and 2, 6 and 18 months after treatment.

The study will be carried out in 4 primary schools; two from Machava J area and two from Costa do Sol area. The schools will be selected based on the following criteria: similar prevalence (> 50%) and intensity of S. haematobium infection; absence or very low levels of S. mansoni infection; a minimum of 2 classes (>35 pupils per class) at each level (3rd and 4th level) and similar distribution of boys and girls.Examinations will include urine for parasitology and haematuria and ultrasonography of upper and lower urinary tract ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00231322
Study type Interventional
Source DBL -Institute for Health Research and Development
Contact
Status Completed
Phase N/A
Start date March 2004
Completion date March 2006

See also
  Status Clinical Trial Phase
Completed NCT01349244 - Hydronephrosis on Ultrasound With CT Finding in Patients With Renal Colic N/A
Recruiting NCT04090255 - Us vs Fluoroscopic Guided Renal Access N/A
Completed NCT03296280 - Evaluation of Implementation of a National Point-of-Care Ultrasound Training Program
Completed NCT03327688 - Point-of-care Ultrasound in Finland N/A
Completed NCT01781845 - Hydronephrosis ARFI Study N/A
Completed NCT02976870 - Hydronephrosis After Anterior Lumbar Interbody Fusion (ALIF) N/A
Completed NCT00555308 - Emergency Department Targeted Ultrasound for the Detection of Hydronephrosis N/A
Completed NCT03873701 - Bedside Ultrasonography in Acute Patients With Suspected Kidney Involvement
Suspended NCT03774719 - Hand-carried Ultrasound to Assess Hydronephrosis N/A
Completed NCT04869462 - DS Titanium Ligation Clip in Urology (Prostatectomy and Nephrectomy)
Not yet recruiting NCT03695991 - Effect of Per-cutaneous Nephrosotomy Drainage on Radioisotope Imaging of Hydronephrotic Kidneys
Active, not recruiting NCT02812420 - Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery Early Phase 1
Completed NCT01323842 - Emergency Department Ultrasound in Renal Colic N/A
Completed NCT00882544 - Prospective Pediatric Pyeloplasty Robotic Surgical Database N/A
Completed NCT01839006 - Clinical Significance of Supranormal Differential Renal Function in the Recovery of Hydronephrosis N/A
Recruiting NCT04250090 - Post-Marketing Follow-Up of Long-term Type Ureteral Stent Set
Recruiting NCT05455307 - Efficacy and Safety of Allium Ureteral Stent for Treating Refractory Ureteral Stricture N/A
Active, not recruiting NCT01140516 - Effectiveness of Antibiotics Versus Placebo to Treat Antenatal Hydronephrosis N/A
Completed NCT04594161 - Effectiveness of Drainage by PCN vs. JJ in Patients With Symptoms of Obstructive Kidney Disease Caused by Urolithiasis N/A
Completed NCT00591968 - Telesonography Adaptation and Use to Improve the Standard of Patient Care Within a Dominican Community N/A